Richard Dilorio

Richard Dilorio (chief executive) discloses dealings in InfuSystem Holdings, Inc to SEC (Form 4). Over a trading history stretching from 15 August 2017 to 17 May 2025, the count stands at 57 filings.

On the open market, the record shows 4 purchases worth €51k and 10 sales worth €2.3M. Sales outweigh purchases by €2.2M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 26 share grants and 17 option exercises.

Half of the purchases are above €11k and half below. 3 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The latest filing, published on 20 May 2025, reports a share grant of €107k in InfuSystem Holdings, Inc. The most recent open-market purchase was published on 23 March 2023, 1,312 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.